EN HU

Nánási Péter Pál

Publication list

Uploaded publications:
275
Publications in DEA:
275
OA:
65
Date range:
1980-2026
2026
1.
Óvári, J., Kovács, Z. M., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Varga, Z., Szentandrássy, N.: Amsacrine modifies action potential configuration without its prolongation via the blockade of multiple ion currents in canine ventricular cells.
Biomed. Pharmacother. 202, 1-14, (article identifier: 119825), 2026.
Journal metrics:
D1 Medicine (miscellaneous) (2025)
D1 Pharmacology (2025)
2.
Kovács, Z. M., Óvári, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Balogh, G., Szentandrássy, N.: The Methanesulfonamide Group: Bright and Dark Sides of hERG Potassium Channel Inhibition.
Pharmaceuticals. 19 (6), 1-19, (article identifier: 882), 2026.
Journal metrics:
Q1 Drug Discovery (2025)
Q2 Molecular Medicine (2025)
Q1 Pharmaceutical Science (2025)
2025
3.
Óvári, J., Kovács, Z. M., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Concentration-dependent electrophysiological effects of amsacrine on canine ventricular cardiomyocytes.
Cor Vasa. 67 (Suppl.), 62, 2025.
4.
Szentandrássy, N., Óvári, J., Kovács, Z. M., Horváth, B., Magyar, J., Bányász, T., Nánási, P. P.: Conclusions from 20 years of cellular ap recordings: ap parameter correlations, solution-, age-, and sex-dependence.
Cor Vasa. 67 (Suppl.), 74-75, 2025.
5.
Óvári, J., Kovács, Z. M., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Domingos, G. J., Fehér, Á., Varga, Z., Szentandrássy, N.: Delavirdine modifies action potential configuration via inhibition of IKr and Ito in canine ventricular myocytes.
Biomed. Pharmacother. 186, 1-13, (article identifier: 117994), 2025.
Journal metrics:
D1 Medicine (miscellaneous)
D1 Pharmacology
6.
Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: The slow delayed rectifier K+ current is differently regulated under baseline conditions and following β-adrenergic stimulation in canine ventricular cardiomyocytes.
Sci Rep. 15 (1), 1-11, (article identifier: 41939), 2025.
Journal metrics:
Q1 Multidisciplinary
2024
7.
Kovács, Z. M., Horváth, B., Dienes, C., Óvári, J., Kiss, D. Z., Hézső, T., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Beta-Adrenergic Activation of the Inward Rectifier K+ Current Is Mediated by the CaMKII Pathway in Canine Ventricular Cardiomyocytes.
Int. J. Mol. Sci. 25 (21), 1-14, (article identifier: 11609), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
8.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: Correction: Kovács et al. ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr. Pharmaceuticals 2023, 16, 488.
Pharmaceuticals. 17 (9), 1-2, (article identifier: 1137), 2024.
9.
Horváth, B., Kovács, Z. M., Dienes, C., Barta, Z., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Relationship between ion currents and membrane capacitance in canine ventricular myocytes.
Sci. Rep. 14 (1), 11241, (article identifier: 11241), 2024.
Journal metrics:
Q1 Multidisciplinary
2023
10.
Kovács, Z. M., Óvári, J., Dienes, C., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Fehér, Á., Varga, Z., Szentandrássy, N.: ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr.
Pharmaceuticals (Basel). 16 (4), 488, (article identifier: 488), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
11.
Ráduly, A. P., Sárkány, F., Kovács, M. B., Juhász, B., Horváth, B., Szentandrássy, N., Nánási, P. P., Édes, I., Csanádi, Z., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: A kardiális miozinaktivátorok klinikai alkalmazhatósága a preklinikai vizsgálatok tükrében.
Cardiol. Hung. 53 (5), 476-483, 2023.
12.
Csemer, A., Kovács, A., Maamrah, B., Pocsai, K., Korpás, K. L., Klekner, Á., Szűcs, P., Nánási, P. P., Pál, B.: Astrocyte- and NMDA receptor-dependent slow inward currents differently contribute to synaptic plasticity in an age-dependent manner in mouse and human neocortex.
Aging Cell. 22 (9), e13939, (article identifier: 13939), 2023.
Journal metrics:
D1 Aging
Q1 Cell Biology
13.
Horváth, B., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Conductance Changes of Na+ Channels during the Late Na+ Current Flowing under Action Potential Voltage Clamp Conditions in Canine, Rabbit, and Guinea Pig Ventricular Myocytes.
Pharmaceuticals (Basel). 16 (4), 560, (article identifier: 560), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
14.
Ráduly, A. P., Tóth, A., Sárkány, F., Horváth, B., Szentandrássy, N., Nánási, P. P., Csanádi, Z., Édes, I., Papp, Z., Borbély, A.: Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels.
ESC Heart Failure. 10 (2), 1326-1335, 2023.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
15.
Naveed, M., Mohammed, A. S. A., Topal, L., Kovács, Z. M., Dienes, C., Óvári, J., Szentandrássy, N., Magyar, J., Bányász, T., Prorok, J., Jost, N., Virág, L., Baczkó, I., Varró, A., Nánási, P. P., Horváth, B.: Selective Inhibition of Cardiac Late Na+ Current Is Based on Fast Offset Kinetics of the Inhibitor.
Biomedicines. 11 (9), 2383, (article identifier: 2383), 2023.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
16.
Ráduly, A. P., Sárkány, F., Kovács, M. B., Bernát, B., Juhász, B., Szilvássy, Z., Pórszász, R., Horváth, B., Szentandrássy, N., Nánási, P. P., Csanádi, Z., Édes, I., Tóth, A., Papp, Z., Priksz, D., Borbély, A.: The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications.
Int. J. Mol. Sci. 24 (1), 446, (article identifier: 446), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2022
17.
Nagy, N., Tóth, N., Nánási, P. P.: Antiarrhythmic and Inotropic Effects of Selective Na+/Ca2+ Exchanger Inhibition: What Can We Learn from the Pharmacological Studies?.
Int. J. Mol. Sci. 23 (23), 14651, (article identifier: 14651), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
18.
Gönczi, M., Csemer, A., Szabó, L., Sztretye, M., Fodor, J., Pocsai, K., Szenthe, K., Keller-Pintér, A., Köhler, Z. M., Nánási, P. P., Szentandrássy, N., Pál, B., Csernoch, L.: Astaxanthin Exerts Anabolic Effects via Pleiotropic Modulation of the Excitable Tissue.
Int. J. Mol. Sci. 23 (2), 917, (article identifier: 917), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
19.
Horváth, B., Szentandrássy, N., Dienes, C., Kovács, Z. M., Nánási, P. P., Chen-Izu, Y., Izu, L. T., Bányász, T.: Exploring the Coordination of Cardiac Ion Channels With Action Potential Clamp Technique.
Front. Physiol. 13, 864002, (article identifier: 864002), 2022.
Journal metrics:
Q2 Physiology
Q1 Physiology (medical)
20.
Horváth, B., Szentandrássy, N., Almássy, J., Dienes, C., Kovács, Z. M., Nánási, P. P., Bányász, T.: Late Sodium Current of the Heart: where Do We Stand and Where Are We Going?.
Pharmaceuticals (Basel). 15 (2), 231, (article identifier: 231), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
21.
Kovács, Z. M., Dienes, C., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 1: modulation of TRPM4.
Pharmaceuticals (Basel). 15 (1), 81, (article identifier: 81), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
22.
Dienes, C., Kovács, Z. M., Hézső, T., Almássy, J., Magyar, J., Bányász, T., Nánási, P. P., Horváth, B., Szentandrássy, N.: Pharmacological Modulation and (Patho)Physiological Roles of TRPM4 Channel-Part 2: TRPM4 in Health and Disease.
Pharmaceuticals (Basel). 15 (1), 40, (article identifier: 40), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
23.
Horváth, B., Kiss, D. Z., Hézső, T., Veress, R., Dienes, C., Kovács, Z. M., Szentandrássy, N., Magyar, J., Bányász, T., Nánási, P. P.: Role of protein kinase A and calcium/calmodulin-dependent protein kinase II in beta-adrenergic regulation of potassium channels.
Acta Physiol. 236 (S725), 103-105, 2022.
24.
Horváth, B., Kiss, D. Z., Veress, R., Kovács, Z. M., Dienes, C., Szentandrássy, N., Bányász, T., Magyar, J., Nánási, P. P.: Role of protein kinase A and calcium/calmodulin-dependent protein kinase II in beta-adrenergic regulation of potassium channels in canine ventricular cardiomyocytes.
J. Mol. Cell. Cardiol. 173 (Supplement), S148, 2022.
25.
Szentandrássy, N., Magyar, Z. É., Hevesi, J., Bányász, T., Nánási, P. P., Almássy, J.: Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases.
Int. J. Mol. Sci. 23 (8), 4435, (article identifier: 4435), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
DEENK University of Debrecen
© 2012 University of Debrecen